Bobak R. Azamian
CIK: 0001827672
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tarsus Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (23 total)
- Sep 4, 2026TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Indirect2.9K shares at avg. $91.27$265K - Sep 4, 2026TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Indirect7.1K shares at avg. $90.27$641K - Sep 2, 2026TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Indirect10K shares at avg. $80.06$801K - Jun 17, 2026TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Indirect4.6K shares at avg. $61.24$281K - Jun 17, 2026TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Indirect5.4K shares at avg. $61.81$335K - Mar 19, 2026TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Direct12K shares at avg. $67.00$802K - Mar 18, 2026TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Direct11.7K shares at avg. $68.71$802K - Mar 17, 2026TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Direct11K shares at avg. $69.42$762K - Mar 15, 2026TARS
Tarsus Pharmaceuticals, Inc.
Exercise(M)Direct66.3K shares- - Mar 5, 2026TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
60.8K shares- - Mar 5, 2026TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
96.7K shares- - Dec 24, 2025TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Indirect5.4K shares at avg. $82.41$449K - Dec 24, 2025TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Indirect557 shares at avg. $83.54$47K - Dec 4, 2025TARS
Tarsus Pharmaceuticals, Inc.
Gift(G)Direct51.9K shares- - Sep 24, 2025TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Indirect6K shares at avg. $55.37$332K - Aug 11, 2025TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Indirect6K shares at avg. $50.00$300K - Mar 24, 2025TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Indirect6K shares at avg. $50.00$300K - Mar 20, 2025TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Direct8.5K shares at avg. $50.11$428K - Mar 19, 2025TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Direct8.6K shares at avg. $47.40$405K - Mar 18, 2025TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Direct7.1K shares at avg. $46.29$330K - Mar 15, 2025TARS
Tarsus Pharmaceuticals, Inc.
Exercise(M)Direct51.4K shares- - Mar 5, 2025TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
90.7K shares- - Mar 5, 2025TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
59.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 4, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 2,900 | $91.27 | $264,683 | Indirect |
| Sep 4, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 7,100 | $90.27 | $640,917 | Indirect |
| Sep 2, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 10,000 | $80.06 | $800,600 | Indirect |
| Jun 17, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 4,582 | $61.24 | $280,602 | Indirect |
| Jun 17, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 5,418 | $61.81 | $334,887 | Indirect |
| Mar 19, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 11,964 | $67.00 | $801,588 | Direct |
| Mar 18, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 11,667 | $68.71 | $801,640 | Direct |
| Mar 17, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 10,972 | $69.42 | $761,676 | Direct |
| Mar 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Exercise(M) | 66,274 | - | $0 | Direct |
| Mar 5, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 60,776 | - | - | Direct |
| Mar 5, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 96,723 | - | - | Direct |
| Dec 24, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 5,443 | $82.41 | $448,558 | Indirect |
| Dec 24, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 557 | $83.54 | $46,532 | Indirect |
| Dec 4, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Gift(G) | 51,885 | - | - | Direct |
| Sep 24, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 6,000 | $55.37 | $332,220 | Indirect |
| Aug 11, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 6,000 | $50.00 | $300,000 | Indirect |
| Mar 24, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 6,000 | $50.00 | $300,000 | Indirect |
| Mar 20, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 8,534 | $50.11 | $427,639 | Direct |
| Mar 19, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 8,551 | $47.40 | $405,317 | Direct |
| Mar 18, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 7,131 | $46.29 | $330,094 | Direct |
| Mar 15, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Exercise(M) | 51,395 | - | - | Direct |
| Mar 5, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 90,736 | - | - | Direct |
| Mar 5, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 59,512 | - | - | Direct |
1-23 of 23 transactions
About Azamian Bobak R.
Azamian Bobak R. (SEC CIK 0001827672) files insider reports with the SEC as President/CEO and Board Chair of Tarsus Pharmaceuticals, Inc. (TARS).
Signal8 holds 14 ownership filings by Azamian Bobak R., all Form 4s, filed between Mar 7, 2025 and Sep 9, 2026. Those filings report 23 transactions, from Mar 5, 2025 to Sep 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Azamian Bobak R.'s filings is in IRVINE, CA.
Recent filings by Azamian Bobak R.
- Sep 4, 2026: Open-market sales of TARS shares (2 lines, Form 4, code S).
- Sep 2, 2026: Open-market sale of TARS shares (Form 4, code S).
- Jun 17, 2026: Open-market sales of TARS shares (2 lines, Form 4, code S).
- Mar 19, 2026: Open-market sale of TARS shares (Form 4, code S).
- Mar 18, 2026: Open-market sale of TARS shares (Form 4, code S).
Other insiders filing for Tarsus Pharmaceuticals, Inc. (TARS)
- PYOTT DAVID E I, Director
- YARNO WENDY L, Director
- LINK WILLIAM J PHD, Director
- Lin Elizabeth Yeu, Chief Medical Officer
- Neervannan Seshadri, Chief Operating Officer
- Goodrich Katherine, Director